Kobe2602
Kobe2602 is a Ras-Raf interaction inhibitor. Kobe2602 inhibits the binding of H-Ras·GTP to c-Raf-1 RBD with a Ki of 149 μM. Kobe2602 has antitumor activity[1].
Product Specifications
CAS Number
454453-49-7
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kobe2602.html
Purity
98.20
Solubility
DMSO : ≥ 250 mg/mL
Smiles
FC(C1=CC([N+]([O-])=O)=C(NNC(NC2=CC=C(F)C=C2)=S)C([N+]([O-])=O)=C1)(F)F
Molecular Formula
C14H9F4N5O4S
Molecular Weight
419.31
Precautions
H315, H319, H335
References & Citations
[1]Shima, Fumi, et al. In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction. Proceedings of the National Academy of Sciences of the United States of America (2013), 110 (20), 8182-8187, S8182/1-S8182/10.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP1-72719 2 mg
Rabbit Polyclonal Rabbit F(ab')2 anti-Feline IgG Secondary Antibody
Sign In for Pricing
View Details 